Anti-inflammatory and antiplatelet effects of amtolmetin guacyl, a new gastroprotective non-steroidal anti-inflammatory drug

Arzneimittel-Forschung/Drug Research

Volumn 51, Issue 9, 2001, Pages 737-742

  Tubaro, E ^a   Belogi, L ^a   Mezzadri, C M ^a  

^a Medosan Ricerca Srl   (Italy)

Author keywords

Amtolmetin guacyl, anti inflammatory effects, antiplatelet effects, rat; CAS 873344 06 7; MED15; Thromboxane

Indexed keywords

ACETYLSALICYLIC ACID; AMTOLMETIN GUACIL; CARRAGEENAN; INDOMETACIN; NONSTEROID ANTIINFLAMMATORY AGENT; PIROXICAM; THROMBOXANE; TOLMETIN; VANILLOID RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTHRITIS; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; MALE; NONHUMAN; PLEURISY; RABBIT; RAT; STRUCTURE ACTIVITY RELATION; THROMBOCYTE AGGREGATION; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 0034834991     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0031-1300108     Document Type: Article

References (26)

1. Evaluation of the gastric tolerability of MED15 in comparison with indomethacin: Double blind study in healthy volunteers
2. Metanalysis of the tolerability of amtolmetin guacyl, a new, efficacious, non-steroidal anti-inflammatory drug, compared with traditional NSAIDS
3. Clinical and gastroscopic evaluation of amtolmetin guacyl versus diclofenac in patients with rheumatoid arthritis
4. A safe non-steroidal anti-inflammatory drug - The search continues
5. Studies on the gastric tolerability of the new nonsteroidal anti-inflammatory drug amtolmetin guacyl
6. The mechanism of action of amtolmetin guacyl, a new gastroprotective non-steroidal anti-inflammatory drug
7. Gastrosparing effect of new anti-inflammatory drug amtolmetin guacyl in the rat: Involvement of nitric oxide
8. Aggregation of blood platelets by adenossteroidal diphosphate and its reversal
9. Protective effect of amtolmetin guacyl versus placebo, a typical NSAID, and misoprostol in healthy volunteers evaluated as gastric electrical activity in alcohol-induced stomach damage
10. Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain
11. Pharmacology of a selective cyclooxygenase-2 inhibitor, L-745,337: A novel nonsteroidal anti-inflammatory agent with an ulcerogenic sparing effect in rat and nonhuman primate stomach
12. NS-398, a novel nonsteroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions
13. Limited anti-inflammatory efficacy of cyclo-oxygenase-2 inhibition in carrageenan-airpouch inflammation
14. Cyclooxygenase 1 contributes to inflammatory responses in rats and mice: Implications for gastrointestinal toxicity
15. Selective inhibitors of cyclooxygenase 2: Are they really effective, selective, and GI safe?
16. Distribution and expression of cyclooxygenase (COX) isoenzymes, their physiological roles, and the categorization of nonsteroidal anti-inflammatory drugs
17. Amtolmetin guacyl versus piroxicam in patients with osteoarthritis
18. Clinical study of the therapeutic activity and of the tolerability of Artromed in comparison with naproxen in patients with osteoarthritis in different localizations
19. Evaluation of the time course of the algic-inflammatory symptomatology in patients with osteoarthritic afflictions during and after treatment with Artromed or diclofenac
20. Cox- 2 is not involved in thromboxane biosynthesis by activated human platelets
21. Meloxicam: Selective COX- 2 inhibition in clinical practice
22. Effects of Celecoxib, a novel cyclooxygenase-2 inhibitor, on platelet function in healthy adults: A randomized, controlled trial
23. Celecoxib for the treatment of pain and inflammation: The preclinical and clinical results
24. Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: Efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects
25. The in vivo assessment of nimesulide cyclooxygenase-2 selectivity
26. Selective cyclo-oxygenase- 2 inhibition by nimesulide in man